Insulin glargine

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.



Insulin glargine

LANTUS, SOLIQUA, SOLIQUASOLIQUASOLOSTAR3060PEN, SOLIQUASOLOSTAR3060PEN, TOUJEODOUBLESTAR, TOUJEOSOLOSTAR – sanofi-aventis Canada Inc. (NOC Search)

Patents:

  • 2490116:

Unknown/Other

Return to the Patented Medicine Litigation page.

Canadian Intellectual Property